rs2307153

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001374259.2(IL12RB2):​c.1394G>A​(p.Gly465Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.019 in 1,610,054 control chromosomes in the GnomAD database, including 342 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.015 ( 21 hom., cov: 32)
Exomes 𝑓: 0.019 ( 321 hom. )

Consequence

IL12RB2
NM_001374259.2 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.840

Publications

22 publications found
Variant links:
Genes affected
IL12RB2 (HGNC:5972): (interleukin 12 receptor subunit beta 2) The protein encoded by this gene is a type I transmembrane protein identified as a subunit of the interleukin 12 receptor complex. The coexpression of this and IL12RB1 proteins was shown to lead to the formation of high-affinity IL12 binding sites and reconstitution of IL12 dependent signaling. The expression of this gene is up-regulated by interferon gamma in Th1 cells, and plays a role in Th1 cell differentiation. The up-regulation of this gene is found to be associated with a number of infectious diseases, such as Crohn's disease and leprosy, which is thought to contribute to the inflammatory response and host defense. Several transcript variants encoding different isoforms and non-protein coding transcripts have been found for this gene. [provided by RefSeq, Apr 2012]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003908336).
BP6
Variant 1-67367960-G-A is Benign according to our data. Variant chr1-67367960-G-A is described in ClinVar as Benign. ClinVar VariationId is 1166571.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0146 (2229/152266) while in subpopulation NFE AF = 0.0226 (1539/68010). AF 95% confidence interval is 0.0217. There are 21 homozygotes in GnomAd4. There are 1067 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 21 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL12RB2NM_001374259.2 linkc.1394G>A p.Gly465Asp missense_variant Exon 11 of 17 ENST00000674203.2 NP_001361188.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL12RB2ENST00000674203.2 linkc.1394G>A p.Gly465Asp missense_variant Exon 11 of 17 NM_001374259.2 ENSP00000501329.1 Q99665-1

Frequencies

GnomAD3 genomes
AF:
0.0147
AC:
2229
AN:
152148
Hom.:
21
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00408
Gnomad AMI
AF:
0.00548
Gnomad AMR
AF:
0.0159
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0225
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0226
Gnomad OTH
AF:
0.0129
GnomAD2 exomes
AF:
0.0139
AC:
3498
AN:
251434
AF XY:
0.0140
show subpopulations
Gnomad AFR exome
AF:
0.00326
Gnomad AMR exome
AF:
0.00971
Gnomad ASJ exome
AF:
0.00268
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0218
Gnomad NFE exome
AF:
0.0220
Gnomad OTH exome
AF:
0.0145
GnomAD4 exome
AF:
0.0195
AC:
28393
AN:
1457788
Hom.:
321
Cov.:
29
AF XY:
0.0190
AC XY:
13804
AN XY:
725540
show subpopulations
African (AFR)
AF:
0.00353
AC:
118
AN:
33416
American (AMR)
AF:
0.0108
AC:
484
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00234
AC:
61
AN:
26110
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39680
South Asian (SAS)
AF:
0.000592
AC:
51
AN:
86186
European-Finnish (FIN)
AF:
0.0222
AC:
1187
AN:
53418
Middle Eastern (MID)
AF:
0.00174
AC:
10
AN:
5754
European-Non Finnish (NFE)
AF:
0.0229
AC:
25410
AN:
1108278
Other (OTH)
AF:
0.0178
AC:
1070
AN:
60224
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
1320
2641
3961
5282
6602
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
898
1796
2694
3592
4490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0146
AC:
2229
AN:
152266
Hom.:
21
Cov.:
32
AF XY:
0.0143
AC XY:
1067
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.00407
AC:
169
AN:
41558
American (AMR)
AF:
0.0159
AC:
243
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00173
AC:
6
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4826
European-Finnish (FIN)
AF:
0.0225
AC:
239
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0226
AC:
1539
AN:
68010
Other (OTH)
AF:
0.0128
AC:
27
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
108
216
323
431
539
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0191
Hom.:
125
Bravo
AF:
0.0137
TwinsUK
AF:
0.0256
AC:
95
ALSPAC
AF:
0.0205
AC:
79
ESP6500AA
AF:
0.00431
AC:
19
ESP6500EA
AF:
0.0190
AC:
163
ExAC
AF:
0.0141
AC:
1711
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.0206
EpiControl
AF:
0.0198

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

IL12RB2-related disorder Benign:1
Mar 06, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.069
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.63
CADD
Benign
0.14
DANN
Benign
0.27
DEOGEN2
Benign
0.069
T;.;.;.;T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.030
N
LIST_S2
Benign
0.52
.;T;T;T;T
MetaRNN
Benign
0.0039
T;T;T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Uncertain
2.9
M;M;.;M;M
PhyloP100
-0.84
PrimateAI
Benign
0.23
T
PROVEAN
Benign
-1.5
N;N;N;N;.
REVEL
Benign
0.038
Sift
Benign
0.13
T;T;T;T;.
Sift4G
Uncertain
0.0070
D;D;D;D;.
Polyphen
0.0020
B;.;.;B;B
Vest4
0.018
MPC
0.18
ClinPred
0.012
T
GERP RS
-3.2
Varity_R
0.096
gMVP
0.48
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2307153; hg19: chr1-67833643; COSMIC: COSV99255249; API